BrightSpring Health Services, Inc. Common Stock
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-95.6% vs price
Base Case (Median)
-67.4% vs price
Bull Case (75th pct.)
-53.6% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $-2.04 | -103.4% | High (40%) |
| PE Comparable | $29.82 | -50.6% | Medium (25%) |
| Graham Number | $16.71 | -72.3% | Medium (40%) |
| EV/EBITDA | $22.69 | -62.4% | Medium (20%) |
| EV/FCF | $39.73 | -34.2% | Medium (20%) |
| Earnings Power Value | $-4.16 | -106.9% | Medium (50%) |
Based on 6 out of 8 methods, BTSG appears overvalued at the current price of $60.38. The base case fair value of $19.70 implies 67.4% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.